Diabetic dyslipidemia and cardiovascular risk Robert H. Eckel Invited Commentary 25 November 2008 Pages: 421 - 423
Pharmacologic management of painful diabetic neuropathy Andrew J. M. Boulton Clinical Trials Report 25 November 2008 Pages: 429 - 430
Gene therapy for the treatment of diabetic neuropathy Marina MataMunmun ChattopadhyayDavid J. Fink OriginalPaper 25 November 2008 Pages: 431 - 436
Management of erectile dysfunction in diabetes: An update for 2008 David PriceGeoffrey Hackett OriginalPaper 25 November 2008 Pages: 437 - 443
The charcot foot: Medical and surgical therapy Jan S. UlbrechtDane K. Wukich OriginalPaper 25 November 2008 Pages: 444 - 451
Diabetic foot problems in India: An overview and potential simple approaches in a developing country Kshitij ShankhdharLakshmi Kant ShankhdharSmita Shankhdhar OriginalPaper 25 November 2008 Pages: 452 - 457
Does blood glucose control improve vascular outcomes in patients with type 2 diabetes? Robert C. Stanton Clinical Trials Report 25 November 2008 Pages: 461 - 463
Vascular endothelial growth factor and diabetic nephropathy Sheldon ChenFuad N. Ziyadeh OriginalPaper 25 November 2008 Pages: 470 - 476
Where does albuminuria come from in diabetic kidney disease? Wayne D. ComperLeileata M. Russo OriginalPaper 25 November 2008 Pages: 477 - 485
Diabetic nephropathy in American Indians, with a special emphasis on the pima Indians Meda E. PavkovWilliam C. KnowlerRobert G. Nelson OriginalPaper 25 November 2008 Pages: 486 - 493
Evaluation and approach to treatment of renal artery stenosis in patients with diabetic nephropathy Jose A. Silva OriginalPaper 25 November 2008 Pages: 494 - 498